Physician profile
James Callaway
NPI 1215198577
$13,495.46
in general payments reported to CMS, 2019-2025
20 companies · $641 in 2025
The $641 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $22.25 · 2021: $1,999 · 2022: $7,680 · 2023: $519 · 2024: $2,007 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771 · Consulting Fee: $1,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.63 |
| Consulting Fee | $1,396.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $10,776.21 | 2021-2025 | |
| Medtronic, INC. | $716.06 | 2022-2024 | Endoflip, Gi Genius, Manoscan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $600.00 | 2019 | |
| Abbvie INC. | $282.14 | 2021-2023 | Creon |
| Celltrion USA INC. | $215.71 | 2024-2025 | Vegzelma, Zymfentra |
| E.R. Squibb & Sons, L.L.C. | $171.99 | 2022-2023 | |
| Steris Corporation | $140.12 | 2024 | |
| Janssen Biotech, INC. | $99.45 | 2020-2025 | Tremfya |
| Anx Robotica Corp | $96.32 | 2022 | |
| Erbe USA INC | $87.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $80.80 | 2022 | |
| Conmed Corporation | $59.84 | 2024-2025 | Conmed Hemostasis, Conmed Biliary, Conmed Generators |
| Lilly USA, LLC | $39.20 | 2025 | Omvoh |
| Regeneron Pharmaceuticals, INC. | $37.85 | 2023 | Dupixent |
| Phathom Pharmaceuticals, INC. | $24.08 | 2025 | Voquezna |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $22.88 | 2025 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Amgen INC. | $18.51 | 2025 | Uplizna |
| Bayer Healthcare Pharmaceuticals INC. | $14.15 | 2019 | |
| Merck Sharp & Dohme LLC | $13.15 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Callaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.